Rezafungin Prophylaxis in Liver Transplant | MicrobiomeTrials← Back to trialsNCT06774144
Rezafungin Prophylaxis in Liver Transplant
ENROLLING_BY_INVITATIONPHASE3INTERVENTIONAL
Trial Details
Start: 2025-10-15Est. Completion: 2028-12
Enrollment target: 385 participants Locations- UPMC Presbyterian, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Chronic Hepatitis B
This is a study of sequential therapy with AHB-137 injection followed by TVAX-008 injection in participants living with …
Multiple LocationsEst. completion Sep 22, 2028
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
This study investigates the safety and tolerability of Nintedanib in patients with bronchiolitis obliterans syndrome (BO…
Riyadh, Saudi ArabiaCompleted Jul 29, 2026
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031